Registered number: 14073660

Quine Medical Writing Ltd
Unaudited Financial Statements
for the year ended 30 April 2024

Statement of Financial Position

as at 30 April 2024

  2024
2023
   
££
 
££
Called up share capital not paid  
  -  
 
  -  
Fixed assets  
  1,095  
 
  85  
Current assets  
29,755    
 
30,590    
Prepayments and accrued income  
-    
 
-    
Creditors: amounts falling due within one year  
( 13,883 )  
 
( 19,399 )  
Net current assets (liabilities)  
  15,872  
 
  11,191  
Total assets less current liabilities  
  16,967  
 
  11,276  
Creditors: amounts falling due after more than one year  
  -  
 
  -  
Provisions for liabilities  
  -  
 
  -  
Accruals and deferred income  
  -  
 
  -  
Net assets  
  16,967  
 
  11,276  
   
Capital and reserves  
  16,967  
 
  11,276  

xbrli:pure 14073660 2023-05-01 2024-04-30 14073660 2022-04-27 2023-04-30 14073660 2024-04-30 14073660 2023-04-30 14073660 2023-05-01 14073660 uk-frs102:WithinOneYear 2024-04-30 14073660 uk-frs102:AfterOneYear 2024-04-30 14073660 uk-frs102:WithinOneYear 2023-04-30 14073660 uk-frs102:AfterOneYear 2023-04-30 14073660 uk-bus:AuditExempt-NoAccountantsReport 2023-05-01 2024-04-30 14073660 uk-bus:FilletedAccounts 2023-05-01 2024-04-30 14073660 uk-bus:Director1 1 2023-05-01 2024-04-30 14073660 uk-bus:Director1 2023-05-01 2024-04-30 14073660 uk-bus:Director1 1 2023-05-01 14073660 uk-bus:Director1 1 2024-04-30 14073660 uk-bus:Micro-entities 2023-05-01 2024-04-30 14073660 uk-bus:PrivateLimitedCompanyLtd 2023-05-01 2024-04-30 iso4217:GBP 14073660 countries:EnglandWales 2023-05-01 2024-04-30 14073660 uk-bus:RegisteredOffice 2023-05-01 2024-04-30

Footnotes to the Statement of Financial Position

Liesje Thomas

1. Arrangements not included in Statement of Financial Position

The company has not entered into any arrangements not shown on the Statement of Financial Position.

2. Average number of employees

The average number of employees in the period was 1.

3. Directors’ benefits: advances, credit and guarantees

Liesje Thomas

During the accounting year Liesje Thomas, a director of the company received an advance from the company that was repaid by 30/04/2024.

The following conditions are attached to advances payable by Liesje Thomas:

  • There is no interest due to be paid on any outstanding amount
  • No fixed date has been set for the amount to be repaid to the company.
Opening balance 01/05/2023 Additional advance Amount repaid Amount written off Amounts waived Interest payable Closing balance 30/04/2024
£ £ £ £ £ £ £
5,786   ( 14,084 )
( 14,084 )
8,298
8,298  
0 0 0 0  

4. Guarantees, contingencies and other financial commitments

There are no guarantees, contingencies or other commitments not included in the financial statements.

Statutory Statements

In accordance with section 414(3) of the Companies Act 2006, these accounts have been prepared in accordance with the FRS 105: The Financial Reporting Standard applicable to the Micro-entities Regime for periods commencing on or after 1 January 2016. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

For the year ending 30/04/2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of Companies Act 2006 with respect to accounting records and the preparation of accounts

Company information

a) The company is registered in England and Wales

b) Company registration number - 14073660

c) The company is a private company and is limited by shares

d) The companies registered office address is W8a Knoll Business Centre 325-327 Old Shoreham Road, Hove, BN3 7GS, United Kingdom



Approved by the board of directors and signed on behalf of the board,

Quine Medical Writing Ltd
Director Liesje Thomas
Date of approval: 26/09/2024
The company was trading for the entire period 2023-05-01 2024-04-30 2024-04-30 Medical Writing 2024-09-26 2024-09-26